ArticleHeart views : the official journal of the Gulf Heart Association
Development and Implementation of Cardio-oncology Services at the National Center for Cancer Care and Research and Heart Hospital: The Qatar Experience.
Article in Heart views : the official journal of the Gulf Heart Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: cardiovascular disease and cancer are two leading causes of mortality worldwide. Advances in cancer therapy have improved survival but increased the risk of treatment-related cardiotoxicity. In response, the National Center for Cancer Care and Research (NCCCR) and Heart Hospital (HH) established a dedicated strategic plan for the development of cardio-oncology service in 2015 to address the prevention, early detection, and management of cardiotoxicity through a multidisciplinary approach in Qatar. Objectives: The objective of this study was to describe the development and implementation of the cardio-oncology service at NCCCR and HH. Methods: A retrospective descriptive study with a mixed-methods approach was conducted. Quantitative data were extracted from the electronic health records for all patients seen in the Cardio-Oncology Clinic during two key phases of service delivery: HH (January 2019 to August 2020) and NCCCR (September 2020 to July 2023). Descriptive qualitative data were obtained from informal staff feedback and clinical observations. Results: Between 2019 and 2023, 4197 patients attended the cardio-oncology clinics (1524 at HH and 2673 at NCCCR), with 77%-82% being noncitizens. Breast cancer was the most common diagnosis (48%), reflecting its high prevalence and cardiotoxic treatment profile. A total of 5289 echocardiographic studies were performed. In 2023, 494 cardiovascular events were recorded, but therapy was held in three cases (0.06%) due to significant cardiotoxicity. Service expansion included the introduction of a clinical nurse specialist-led clinic and a dedicated echocardiography unit. Conclusion: cardio-oncology program demonstrates that early, structured cardiac surveillance within a multidisciplinary framework can effectively minimize therapy interruptions and optimize cancer patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.